Damon Runyon Funds Young Investigators Studying Molecular Basis of Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $3.6 million to nine young investigators who are pursuing a range of efforts to better understand, and eventually treat, cancer at the molecular level.

The foundation said yesterday that it has named six new Damon Runyon Clinical Investigators, each of whom will receive $450,000 for three years to launch their projects, and three continuation grants of $300,000 each to previous awardees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.